uniQure (QURE) Share-based Compensation (2016 - 2026)
uniQure (QURE) recorded quarterly Share-based Compensation of $5.1 million in Q1 2026, up 9.16% quarter-over-quarter from $4.7 million in Q4 2025, and up 15.42% on a YoY basis from $4.4 million in Q1 2025.
uniQure (QURE) Share-based Compensation (2016 - 2026) Analysis & Trends
uniQure's Share-based Compensation history runs 11 years deep, the most recent figure standing at $5.1 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 15.42% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $18.4 million (up 18.81% YoY), while the FY2025 annual figure was $17.7 million, down 20.57% from the prior year.
- Share-based Compensation was $5.1 million for Q1 2026 at uniQure, up from $4.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $11.9 million in Q4 2022 to a low of $8000.0 in Q3 2023.
- Historically, Share-based Compensation has averaged $4.6 million across 5 years, with a median of $4.7 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation jumped 62066.67% in 2022, then slumped 99.79% in 2023.
- A 5-year view of Share-based Compensation shows it stood at $11.9 million in 2022, then slumped by 40.9% to $7.0 million in 2023, then sank by 32.55% to $4.7 million in 2024, then dropped by 1.81% to $4.7 million in 2025, then rose by 9.16% to $5.1 million in 2026.
- The last three Share-based Compensation figures came in at $5.1 million (Q1 2026), $4.7 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.09 Mn |
| Mar 31, 2026 | 5.09 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 5.08 Mn |
| Jun 30, 2025 | 5.08 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.86 Mn |
| Mar 31, 2024 | 7.19 Mn |
| Mar 31, 2024 | 7.19 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Dec 31, 2023 | 7.04 Mn |